Table 2.
Patient characteristics extracted from the Research Derivative.
| Participants N = 2605 |
Non-Participantsa N = 29,946 |
|
|---|---|---|
| Age, years median (IQR) | 68.9 (61.3–75.9) | 68.7 (60.4–76.6) |
| Sex, n (%) | ||
| Male | 1780 (68.3) | 20,116 (67.2) |
| Race, n (%) | ||
| White | 2310 (88.7) | 25, 329 (84.6) |
| Black | 191 (7.3) | 1, 891 (6.3) |
| Other | 38 (1.5) | 466 (1.6) |
| Missing | 66 (2.5) | 2, 260 (7.5) |
| Health Literacy (n (%) adequate) | 2168 (83.2%) | – |
| Subjective Numeracy (n (%) adequate) | 2196 (84.3%) | – |
| Number of Visits in past 2 years, median (IQR) | 17.0 (8.0–34.0) | 8.0 (4.0–18.0) |
| Hospitalized in past 2 years, n (%) | 1304 (50.1) | 10, 352 (34.6) |
| Clinical Variables median (IQR) | ||
| Body Mass Index, (kg/m2) | 29.5 (26.2–33.6) | 28.8 (25.5–32.9) |
| N with measure (%) | 2491 (95.6) | 20,008 (66.8) |
| Systolic Blood Pressure, (mmHg) | 126 (119–135) | 127 (118–137) |
| Diastolic Blood Pressure, (mmHg) | 70 (65–76) | 70 (64–77) |
| N with measure (%) | 2573 (98.8) | 23,984 (80.0) |
| HbA1c, (%) | 6.3 (5.7–7.2) | 6.2 (5.6–7.3) |
| N with measure (%) | 1051 (40.3) | 7201 (24.0) |
| Low Density Lipoprotein, mg/dL | 81.0 (64.0–100.0) | 83.0 (66.0–106.0) |
| N with measure (%) | 1706 (65.5) | 10,381 (34.7) |
| Co-morbiditiesb, N (%) | ||
| Hypertension | 1988 (76.3) | 14,900 (49.8) |
| Type 2 Diabetes | 989 (38.0) | 9942 (33.2) |
| Hyperlipidemia | 2051 (78.7) | 14,108 (47.1) |
| Congestive Heart Failure | 589 (22.6) | 4417 (14.7) |
| Depression | 164 (6.3) | 1043 (3.5) |
| Smoking | 208 (8.0) | 2130 (7.1) |
| Medications, N (%) | ||
| ACEI/ARBs | 1955 (75.0) | 16,753 (55.9) |
| Beta Blockers | 1998 (76.7) | 17,724 (59.2) |
| Anticoagulants | 1036 (39.8) | 8716 (29.1) |
| Non Aspirin Antiplatelet Agents | 1072 (41.2) | 10,187 (34.0) |
| Aspirin | 2332 (89.5) | 20,792 (69.4) |
| Statins | 2331 (89.5) | 20,415 (68.2) |
IQR= Interquartile range; ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin-receptor blocker.
a
Non-participants include those who were approached and declined and those who were not approached.
b
Each co-morbid condition was defined as present if there was 1 specified inpatient code, 2 specified outpatient codes separated by 30 days, 1 specified procedure code, or prescription for a medication defining that comorbid condition in the 730 days (2 years) prior to the search query.